Thursday, May 11, 2023 2:00 PM – 4:00 PM ET Room 204ABC
Vaccination and Vaccine-induced Responses against Pathogens at Target Sites
- Mangala Rao, Walter Reed Army Inst. of Res.
- Todd Bradley, Univ. of Kansas Med. Ctr.
- Dennis Lapuente, Univ. Hosp. Erlangen, Germany, Adenoviral vector vaccines are effective mucosal booster modalities to elevate systemic and establish mucosal immunity against SARS-CoV-2
- Qin Xu, NIAID, NIH, mRNA vaccination induces persistent pharyngeal mucosal B cell responses to SARS-CoV-2 in children
- Wenxia Jiang, Indiana Univ. Sch. of Med., Boosting location of COVID-19 mRNA vaccine regulates the germinal center reaction
- Devdoot Majumdar, Univ. of Vermont, Understanding mechanisms of adjuvancy in muscle by mRNA/lipid nanoparticles
- Eric S. Geanes, Children's Mercy Kansas City, Blocking respiratory syncytial virus infection utilizing decoy ICAM-1 receptor proteins
- Chunhong Dong, Georgia State Univ., Particulate characteristics of engineered nanoparticle vaccines modulate vaccine immunogenicity in an intranasal route
- Allison N. Bucsan, NIAID, NIH, Visualizing the early immune response to Mycobacterium tuberculosis infection in macaques immunized with intravenous BCG